Dr. Martens plc
DOCS.L · LSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | £490 | £890 | £1,424 | £2,388 |
| - Cash | £156 | £111 | £158 | £228 |
| + Debt | £404 | £477 | £452 | £394 |
| Enterprise Value | £738 | £1,256 | £1,718 | £2,554 |
| Revenue | £788 | £877 | £1,000 | £908 |
| % Growth | -10.2% | -12.3% | 10.1% | – |
| Gross Profit | £512 | £575 | £618 | £579 |
| % Margin | 65% | 65.6% | 61.8% | 63.7% |
| EBITDA | £111 | £196 | £235 | £265 |
| % Margin | 14% | 22.4% | 23.5% | 29.2% |
| Net Income | £5 | £69 | £129 | £181 |
| % Margin | 0.6% | 7.9% | 12.9% | 19.9% |
| EPS Diluted | 0.005 | 0.07 | 0.13 | 0.18 |
| % Growth | -92.9% | -46% | -27.8% | – |
| Operating Cash Flow | £196 | £168 | £77 | £184 |
| Capital Expenditures | -£19 | -£28 | -£51 | -£25 |
| Free Cash Flow | £178 | £140 | £26 | £159 |